Par Pharmaceutical, Inc.赞助的临床试验
总计5167个结果
-
Par Pharmaceutical, Inc.PharmaKinetics Laboratories Inc.完全的
-
Par Pharmaceutical, Inc.Novum Pharmaceutical Research Services终止
-
Par Pharmaceutical, Inc.Novum Pharmaceutical Research Services完全的确定美联储条件下的生物等效性
-
Par Pharmaceutical, Inc.Novum Pharmaceutical Research Services终止
-
Par Pharmaceutical, Inc.Novum Pharmaceutical Research Services完全的确定禁食下的生物等效性研究
-
Par Pharmaceutical, Inc.Phoenix International Life Sciences, Inc.完全的
-
Par Pharmaceutical, Inc.Phoenix International Life Sciences, Inc.完全的
-
Par Pharmaceutical, Inc.BASi Clinical Research Unit完全的
-
Tetraphase Pharmaceuticals, Inc.PRA Health Sciences完全的
-
Ultragenyx Pharmaceutical IncPRA Health Sciences招聘中
-
Enanta Pharmaceuticals, IncPharmaceutical Research Associates完全的
-
Enanta Pharmaceuticals, IncPharmaceutical Research Associates完全的
-
Enanta Pharmaceuticals, IncPharmaceutical Research Associates完全的
-
Alexza Pharmaceuticals, Inc.Pharmaceutical Research Associates未知
-
Enanta Pharmaceuticals, IncPharmaceutical Research Associates完全的
-
Roswell Park Cancer InstituteAVEO Pharmaceuticals, Inc.撤销III期肾细胞癌 | II期肾细胞癌